Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and Left Ventricular Hypertrophy

pyrazines has been researched along with Left Ventricular Hypertrophy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birnbaum, Y; Keyes, KT; Lin, Y; Perez-Polo, JR; Ye, Y; Zhang, C1
Carrier, L1
Barnett, CW; Doggrell, SA; Petcu, EB1

Other Studies

3 other study(ies) available for pyrazines and Left Ventricular Hypertrophy

ArticleYear
The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 298, Issue:5

    Topics: Animals; Blood Glucose; Blotting, Western; Body Weight; Culture Media; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dipeptidyl-Peptidase IV Inhibitors; Eicosanoids; Glucagon-Like Peptide 1; Hypertrophy, Left Ventricular; Hypoglycemic Agents; In Vitro Techniques; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Organ Size; Phospholipases A2; Pioglitazone; Prostaglandin-Endoperoxide Synthases; Protective Agents; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Triazoles

2010
Too much of a good thing is bad: proteasome inhibition induces stressed hearts to fail.
    Cardiovascular research, 2010, Dec-01, Volume: 88, Issue:3

    Topics: Adaptation, Physiological; Animals; Boronic Acids; Bortezomib; Calcineurin; Dose-Response Relationship, Drug; Heart Failure; Hypertrophy, Left Ventricular; Mice; Models, Animal; Myocytes, Cardiac; NFATC Transcription Factors; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Signal Transduction; Stress, Physiological; Ubiquitin

2010
Affinity constants and beta-adrenoceptor reserves for isoprenaline on cardiac tissue from normotensive and hypertensive rats.
    The Journal of pharmacy and pharmacology, 1998, Volume: 50, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Female; Heart; Heart Atria; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Isoproterenol; Male; Myocardial Contraction; Myocardium; Papillary Muscles; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta

1998